Example: Heart Attack

Clinical Trials Sponsored by Medpace, Inc

Total 72 results

NCT04663464

Recruiting

Study to Evaluate and Compare the PK Profiles of Abaloparatide-SC and Abaloparatide-sMTS in a Cohort of Healthy Men and Healthy Women.

Conditions: Healthy Volunteers
NCT04406636

Active, not recruiting

Natural History Study in Huntington Disease Gene Expansion Carriers (HDGECs) - SHIELD HD

Conditions: Huntington Disease
NCT04160091

Terminated

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis

Conditions: Osteoarthritis of the Shoulder; Adhesive Capsulitis
NCT03815695

Recruiting

A SAD/MAD to Assess the Safety, Pharmacokinetics and Pharmacodynamics of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients

Conditions: Healthy Volunteers; Sickle Cell Disease
NCT03635996

Completed

Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302

Conditions: Paroxysmal Supraventricular Tachycardia
NCT03545607

Recruiting

MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study

Conditions: Ischemic Stroke
NCT03226899

Terminated

A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment

Conditions: Gout; Chronic Kidney Disease (CKD)
NCT04632381

Not yet recruiting

Intravenous Zotatifin in Adults With Mild or Moderate COVID-19

Conditions: Corona Virus Infection
NCT02846753

Unknown status

Implantation of the Venus P-Valve™ in the Pulmonic Position in Patients With Native Outflow Tracts

Conditions: Pulmonary Regurgitation
NCT04622007

Not yet recruiting

Tomivosertib With Anti-PD-(L)1 in Subjects With NSCLC. 1st Line Therapy or Progressing on 1st Line Anti-PD-(L)1 Therapy

Conditions: Non-small Cell Lung Cancer
NCT04606602

Recruiting

Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a)

Conditions: Hyperlipidemias; Dyslipidemias; Elevated Lp(a)
NCT04366115

Not yet recruiting

Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS

Conditions: ARDS; Covid19; Influenza, Human
NCT04329728

Recruiting

The WWRD Study: AVM0703 for Treatment of Leukemia or Lymphoma

Conditions: Lymphoid Malignancies
NCT02542631

Completed

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

Conditions: Diabetes Mellitus, Type 2
NCT02379923

Completed

The Asahi Intecc PTCA Chronic Total Occlusion Study

Conditions: Coronary Artery Disease; Coronary Artery Chronic Total Occlusion
NCT02296190

Completed

Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm

Conditions: Paroxysmal Supraventricular Tachycardia (PSVT)
NCT02178098

Completed

Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension

Conditions: Hypercholesterolemia; Hypertension
NCT02150733

Completed

Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic Impairment

Conditions: Hepatic Impairment; Solid Tumor; Cancer
NCT03687255

Completed

Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections

Conditions: Urinary Tract Infections
NCT03680612

Completed

Cefepime/AAI101 Phase 2 Study in Hospitalized Adults With cUTI

Conditions: Urinary Tract Infections
NCT03625401

Active, not recruiting

Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease

Conditions: Alzheimer Disease, Early Onset
NCT02072161

Completed

Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy

Conditions: Hypercholesterolemia
NCT03549260

Completed

Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction

Conditions: LDL Cholesterol
NCT03545438

Completed

Study to Evaluate the Safety, PK, and Pharmacodynamics of LIB003

Conditions: Hypercholesterolemia
NCT03536754

Active, not recruiting

A Study of CCX140-B in Subjects With FSGS

Conditions: FSGS; Focal Segmental Glomerulosclerosis; Glomerulosclerosis